Despite recent progress and the publishing of several clinical guidelines on the management of advanced basal cell carcinoma, there is still no comprehensive set of clinical guidelines addressing the complexity inherent to the use of Hedgehog pathway inhibitors in the treatment of advanced basal cell carcinoma in real-world clinical practice. To develop practical and valuable tools that help specialists improve the clinical management of these patients, we sought the opinion of expert physicians with extensive knowledge and experience in the treatment of advanced basal cell carcinoma.
De Giorgi V., Scarfi F., Trane L., Silvestri F., Venturi F., Zuccaro B., et al. (2021). Treatment of advanced basal cell carcinoma with hedgehog pathway inhibitors: A multidisciplinary expert meeting. CANCERS, 13(22 5706), 1-11 [10.3390/cancers13225706].
Treatment of advanced basal cell carcinoma with hedgehog pathway inhibitors: A multidisciplinary expert meeting
Venturi F.;Dika E.;
2021
Abstract
Despite recent progress and the publishing of several clinical guidelines on the management of advanced basal cell carcinoma, there is still no comprehensive set of clinical guidelines addressing the complexity inherent to the use of Hedgehog pathway inhibitors in the treatment of advanced basal cell carcinoma in real-world clinical practice. To develop practical and valuable tools that help specialists improve the clinical management of these patients, we sought the opinion of expert physicians with extensive knowledge and experience in the treatment of advanced basal cell carcinoma.| File | Dimensione | Formato | |
|---|---|---|---|
|
cancers-13-05706.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
269.88 kB
Formato
Adobe PDF
|
269.88 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
